South African company Felbridge completes country’s first commercial export of medical cannabis to Europe
Establishes itself as the South African leader in cannabis cultivation and supplier of cannabis and hemp raw materials to global markets
STELLENBOSCH, WEST CAPE, SOUTH AFRICA, June 25, 2021 /EINPresswire.com/ – Felbridge, a leading South African grower and supplier of cannabis and hemp raw materials, is pleased to announce that it has successfully exported the first South African commercial shipment of Dry Flower cannabis to Switzerland.
The 320kg shipment was shipped from Cape Town International Airport and makes Felbridge a leading producer in the global market and directly links African culture to European consumption. The shipment is the first in a large multi-year pick-up agreement with similar-sized shipments expected to be exported according to the company’s production schedule. The export follows Felbridge’s announcement that it had recently exported its first shipment of in vitro tissue culture of cannabis to a licensed producer in North Macedonia.
Leslie Zetler, CEO of Felbridge, commented: “The export of the first commercial shipment of medical cannabis from South Africa to Europe represents our most significant milestone to date. This is a major achievement not only for our Group but for the South African cannabis and hemp industry and it reinforces our belief that our genetics, which are developed using artificial intelligence breeding technologies, will continue to be successful. experience strong demand from the European market. We believe we have taken a giant first step in responding to the call from President Ramaphosa who, in his State of the Nation 2020 address, called for the development of local industry in line with global trends.
Felbridge, who obtained his cultivation license in 2020, is not only developing his own distribution channel for his dry flower offering and starter material, but is also positioning himself to help other licensed growers who are using his genetics with opportunities. marketing in world markets.
Navigating the highly regulated global cannabis market can be difficult for small growers and Felbridge bridges this gap by providing licensed growers with genetically superior cannabis and hemp genetics in the form needed – whether in seeds, clones. rooted or in vitro tissues, which meet the qualitative and regulatory requirements of its customers. Our existing genetic catalog has unique and predictable characteristics, thus maximizing production potential, while minimizing risk. As a result of this export we are now confident that the regulation, market and logistics have proven successful as expected and we will soon be approaching other licensed growers with harvest opportunities using Felbridge genetics. We will particularly focus on emerging farmers with the skills, licenses and infrastructure required to cultivate high quality medical cannabis flowers for export to our existing customers as well as to establish new markets for our products. Direct debit agreements not only allow licensees to consolidate their business plans and secure financing, but they also allow the industry to grow and prosper. South Africa has great potential to become an important producer for the world market, thus generating significant export revenues for the economy. This leads to increased employment opportunities, skills development and new investments in the sector. Zetler added.
Felbridge has forged key relationships with international companies and local institutions which will provide a solid platform on which to grow. It is the authorized distributor of Puregene based in Switzerland for the African market and distributes their genetics through seeds, rooted clones and tissue culture and has also signed a cooperation agreement with Perfect Plants, a leading biogenetics company. based in the Netherlands, allowing it to expand its starter material offering by using Perfect Plants’ extensive genetic library and distributing it through in vitro tissue cultures, seeds or rooted clones for sale on world markets. As a full member of the South African National Seed Organization (SANSOR), Felbridge plans to start production of cannabis and hemp seeds in the fourth quarter of 2021.
The company aims to become South Africa’s leading grower serving the international market with high quality medical cannabis and hemp products as well as raw materials and firmly believes it is on track to meet its targets. “Felbridge continues to implement its strategy and has now successfully completed exports of dry flowers and in vitro tissue to Europe and also supplies local licensed growers with seeds, rooted clones and tissue culture. Our order backlog continues to grow, which is a testament to the quality of service and products we offer and this will undoubtedly provide a solid platform for future growth. Felbridge has proven to the market that we not only have levies, but we have it and will continue to do so as the business and industry grows. This would not have been possible without our dedicated team of employees who have worked tirelessly to ensure that our quality products are brought to market in a safe and responsible manner, thus meeting all regulatory requirements. Added Mr. Zetler.
Email: [email protected]
Leslie Zetler, Chairman and CEO: + 27-82-901 6050
Barry Zetler, CFO: + 27-82-888 2100
For more information on Felbridge, visit www.felbridge.co.za
For more information on Puregene, visit www.puregene.com
For more information about Perfect Plants, visit www.perfectplants.nl
write us here
Felbridge (Pty) Limited
Visit us on social networks: